Increasing Clinical Trial Failures Highlighted In GAO Report On Drug R&D
Executive Summary
A "systematic analysis" of why drugs fail during clinical testing could help curb the rising number of trial failures and prevent companies from repeating others' trial mistakes, the Government Accountability Office suggests in a recent report